AI-generated summary
The authors studied a new therapeutic approach for secondary osteoarthritis in patients with rheumatoid arthritis who were on basis therapy. They assessed changes in cartilage oligomeric matrix protein, disease activity on DAS28, and cytokine profiles. The authors report that combining an IL-1 inhibitor with laser therapy showed advantages in treatment.
- Who or what was studied
- Patients with rheumatoid arthritis and secondary osteoarthritis receiving basis therapy
- Limits stated in the abstract
- The abstract does not report sample size, control group, or statistical details, so the strength of the findings cannot be judged.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Osteoarthritis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.